PRE-MARKET REPORT
The domestic equity market benchmark indices, Sensex and Nifty 50, are expected to open higher on Wednesday, following gains in global markets.
Gift Nifty was trading around the 23,845 level, a premium of nearly 60 points from the Nifty futures’ previous close, indicating a positive start for the Indian stock market indices.
Asian markets traded higher on Wednesday, following Wall Street’s overnight rally and ahead of key economic data from the region.
Japan’s Nikkei 225 gained 0.71%, while the Topix index rallied 0.88%. South Korea’s Kospi surged 0.93%, while the Kosdaq advanced 0.98%. Hong Kong’s Hang Seng index futures indicated a stronger opening.
The US stock market ended higher on Tuesday led by energy stocks and US-China trade optimism. The Dow Jones Industrial Average gained 134.13 points, or 0.30%, to 44,556.04, while the S&P 500 rose 43.31 points, or 0.72%, to 6,037.88. The Nasdaq Composite closed 262.06 points, or 1.35%, higher at 19,654.02.
STOCKS TODAY
Asian Paints: Asian Paints reported a 23.3 percent year-on-year drop in consolidated net profit for Q3FY25, which came in at ₹1,110.48 crore compared to ₹1,447.72 crore in the same quarter last year. On a sequential basis, net profit improved by 60 percent. Revenue from sales fell 6.1 percent year-on-year to ₹8,521.51 crore, down from ₹9,074.94 crore in Q3FY24. However, on a sequential basis, revenue showed a 6.5 percent increase.
Tata Power: Tata Power Ltd. posted strong year-on-year growth across key financial metrics in Q3FY25. Revenue increased 5 percent to ₹15,391 crore, while net profit rose 10.3 percent to ₹1,187 crore from ₹1,076 crore in the same period last year. EBITDA witnessed a robust 39 percent year-on-year growth to ₹3,352 crore, with margins improving significantly by over 500 basis points to 21.8 percent from 16.5 percent in the previous year.
PC Jeweller: PC Jeweller Ltd. reported a strong financial recovery in Q3FY25, with net profit reaching ₹148 crore, a turnaround from the ₹197.98 crore net loss in the same period last year. Revenue from core operations surged 1,496 percent year-on-year to ₹639.45 crore, up from ₹40.06 crore. For 9M FY25, revenue stood at ₹1,544 crore, significantly higher than ₹141 crore in 9M FY24, reflecting the company’s strong festive season performance.
Muthoot FinCorp: Muthoot FinCorp, a part of the Muthoot Pappachan Group, launched Tranche IV of its secured, redeemable non-convertible debentures (NCDs). The subscription window is open from February 4 to February 17, 2025, with an issue size of ₹100 crore and a green shoe option of ₹300 crore, allowing the company to raise to ₹400 crore within its ₹2,000 crore shelf limit. The NCDs offer yields between 9.38 percent and 10.10 percent per annum, depending on the selected tenure, ranging from 18 to 72 months.
Lupin: Drug manufacturer Lupin Ltd. received tentative approval from the U.S. FDA for its generic version of a combination HIV treatment. The approval covers Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets, which are therapeutically equivalent to Symtuza tablets by Janssen Products, LP.
Lemon Tree Hotels: Lemon Tree Hotels reported a 76.6 percent year-on-year increase in net profit, which stood at ₹62.5 crore in Q3FY25, up from ₹35.4 crore last year. Revenue rose 22.4 percent year-on-year to ₹355.2 crore, while EBITDA grew 30.5 percent to ₹184.2 crore. Margins improved to 51.9 percent from 48.7 percent. The company’s investor presentation highlighted a 7 percent year-on-year rise in Gross ARR to ₹6,763, while occupancy increased 826 basis points to 74.2 percent, leading to a RevPAR of ₹5,018